Bruker's Q4 Revenues Drop 9 Percent; Shares Rise as It Beats Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker today reported that its fourth-quarter revenues fell 9 percent and its profit declined 35 percent. But its shares rose in early Tuesday trade as the firm beat analysts' consesus estimates for revenue and earnings per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.